JMIR Dermatology editor in chief Robert Dellavalle, MSPH, MD, PhD, and the editorial board welcome submissions to a special theme issue celebrating the 25th anniversary milestone of the Cochrane Skin Group and reflecting on the achievements and impact of the work of Cochrane Skin authors. Since its inception, Cochrane Skin has published over 125 systematic reviews on a broad range of interventions and conditions, many of which are cited in internationally recognized guidelines.

This JMIR Dermatology theme issue calls for research letters or viewpoints highlighting the findings and influence of high-impact Cochrane Skin reviews. Authors can summarize findings from their Cochrane reviews (see JDerm’s Cochrane Corner for examples) or provide a broader commentary on the impact of the review on the field.

JMIR Publications will not charge any article processing fees for these submissions.

All articles submitted to this theme issue will be shared and published rapidly through the following mechanisms:

JMIR Preprints are immediately available after submission (with DOI); authors should select the preprint option upon submission.
All peer-reviewed research publications collated as part of this theme issue will be immediately and permanently made open access. This is the standard for all titles within the JMIR Publications portfolio.

Important dates:

Submission Deadline: December 31, 2022
Notification of initial decision to authors: February 28, 2023
Final version due: May 31, 2023
Theme issue publication date: August 31, 2023

(All deadlines are 11:59 PM EST on the above mentioned dates.)

How to submit:

Visit JMIR Dermatology and submit by selecting “Theme Issue (2022): Celebrating Cochrane Skin: 25 Years of Evidence-Based Dermatology” in the “Section drop-down list”
See special additional article types for JMIR Dermatology for article requirements
See the “How do I submit to a theme issue?” help article in our knowledge base and consult our Instructions for Authors

Please direct questions about this theme issue to the editor in chief Robert Dellavalle via ed-support@jmir.org

About the editors:

Robert Dellavalle, MSPH, MD, PhD, Editor in Chief, JMIR Dermatology; Professor, University of Colorado, Anschutz Medical Campus; Chief of Dermatology, Rocky Mountain Regional VA Medical Center; Joint Co-ordinating Editor, Cochrane Skin

Dr Dellavalle is the Dermatology Service Chief for the US Department of Veterans Affairs Eastern Colorado Health Care System. He serves as a professor of dermatology at the University of Colorado School of Medicine. He received undergraduate and master's degrees in philosophy at University of California, Los Angeles before matriculating from the MD/PhD Medical Scientist Training Program at the University of Chicago. He subsequently completed a dermatology residency, fellowship in dermatology research, and a master of science in public health at the University of Colorado. Dr Dellavalle is a funded skin cancer prevention investigator and has published over 300 PubMed-indexed dermatology research articles. He serves as the editor in chief of JMIR Dermatology and the joint co-ordinating editor of Cochrane Skin.

Robert Boyle, Clinical Reader in Paediatric Allergy, Imperial College; Associate Professor of Evidence-based Dermatology, University of Nottingham; Joint Coordinating Editor, Cochrane Skin; Editor in Chief, Clinical and Experimental Allergy

Dr Boyle has expertise in clinical trials, systematic reviews, and allergy prevention. He trained in pediatric allergy and immunology at the Royal Children’s Hospital and Melbourne University. His PhD focused on dietary interventions for eczema prevention. His clinical research aims to develop new strategies for preventing, diagnosing, and treating inflammatory conditions that affect young people, particularly allergic diseases. He has conducted numerous evidence syntheses to influence infant feeding guidance. Dr Boyle is the joint co-ordinating editor of Cochrane Skin and the editor in chief of Clinical and Experimental Allergy.

About the Journal

Focus and Scope